HIMS Commentator
TSLL Gain Hunter(Video) Top Analyst Deep Dive: Uncovering the Truth Behind Hims' Growth
Hims house podcast on April 17th. This episode features a deep-dive interview with renowned healthcare analyst David Marrs, covering a wide range of topics including Hims' business developments, the GLP-1 drug market, peptide products, compound drug regulations, international expansion, AI technology applications, sleep health, mental health, and corporate governance.$Hims & Hers Health(HIMS.US) $Defiance Daily Target 2X Long HIMS ETF(HIMZ.US)
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
